Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cynthia Behling

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Nature Communications|June 23, 2026
The metabolic vulnerability index predicts outcomes in patients with metabolic dysfunction associated steatotic liver diseaseMohammad S Siddiqui, Mark L Van Natta, Margery A Connelly, et al.
Journal of Hepatology|December 17, 2022
Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver diseaseArun J Sanyal, Stephen A Williams, Joel E Lavine, et al.
Hepatology (Baltimore, Md.)|March 25, 2022
Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity scoreRish K Pai, Vipul Jairath, Malcolm Hogan, et al.
Gastroenterology|July 1, 2019
Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver DiseaseJeffrey B Schwimmer, Jethro S Johnson, Jorge E Angeles, et al.
Gastrointestinal Endoscopy|July 24, 2007
EUS-guided FNA diagnostic yield of malignancy in solid pancreatic masses: a benchmark for quality performance measurementThomas J Savides, Michael Donohue, Gordon Hunt, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 16, 2018
Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver diseaseMustafa R Bashir, Tanya Wolfson, Anthony C Gamst, et al.
Gut|November 1, 2014
Reproducibility of histological assessments of disease activity in UCMahmoud H Mosli, Brian G Feagan, Guangyong Zou, et al.
Hepatology (Baltimore, Md.)|May 12, 2017
Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver diseaseJeffrey B Schwimmer, Cynthia Behling, Jorge Eduardo Angeles, et al.
Journal of Hepatology|October 10, 2025
Consensus position statements for the standardized application of histological grading and staging systems in MASH clinical trialsCarolin Lackner, Annette S H Gouw, Venancio Avancini Ferreira Alves, et al.
Plos One|April 15, 2022
Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithmsTinsay A Woreta, Mark L Van Natta, Mariana Lazo, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Nature Communications|June 23, 2026
The metabolic vulnerability index predicts outcomes in patients with metabolic dysfunction associated steatotic liver diseaseMohammad S Siddiqui, Mark L Van Natta, Margery A Connelly, et al.
Journal of Hepatology|December 17, 2022
Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver diseaseArun J Sanyal, Stephen A Williams, Joel E Lavine, et al.
Hepatology (Baltimore, Md.)|March 25, 2022
Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity scoreRish K Pai, Vipul Jairath, Malcolm Hogan, et al.
Gastroenterology|July 1, 2019
Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver DiseaseJeffrey B Schwimmer, Jethro S Johnson, Jorge E Angeles, et al.
Gastrointestinal Endoscopy|July 24, 2007
EUS-guided FNA diagnostic yield of malignancy in solid pancreatic masses: a benchmark for quality performance measurementThomas J Savides, Michael Donohue, Gordon Hunt, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 16, 2018
Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver diseaseMustafa R Bashir, Tanya Wolfson, Anthony C Gamst, et al.
Gut|November 1, 2014
Reproducibility of histological assessments of disease activity in UCMahmoud H Mosli, Brian G Feagan, Guangyong Zou, et al.
Hepatology (Baltimore, Md.)|May 12, 2017
Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver diseaseJeffrey B Schwimmer, Cynthia Behling, Jorge Eduardo Angeles, et al.
Journal of Hepatology|October 10, 2025
Consensus position statements for the standardized application of histological grading and staging systems in MASH clinical trialsCarolin Lackner, Annette S H Gouw, Venancio Avancini Ferreira Alves, et al.
Plos One|April 15, 2022
Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithmsTinsay A Woreta, Mark L Van Natta, Mariana Lazo, et al.
Pageof 9